Health ❯ Healthcare ❯ Public Health

Chronic Diseases

Diabetes Obesity Diabetes Management Cardiovascular Health Hypertension Type 2 Diabetes Autoimmune Disorders Neurodevelopmental Disorders Heart Health Kidney Disease

FDA Approves AstraZeneca’s Baxfendy for Hard-to-Control Hypertension

The oral aldosterone‑blocking pill showed near double‑digit drops in systolic pressure in late‑stage testing.

Abbott to Commercialize Novo Nordisk’s Semaglutide in India Under Extensior Brand

Metformin Linked to 37% Lower Odds of Intermediate Macular Degeneration in Diabetic Patients

UK Opens Phase 2 Trial of mRNA EBV Vaccine for Newly Diagnosed MS Patients

Real-World Study Finds Semaglutide and Tirzepatide Cut Cardiovascular Risk in Type 2 Diabetes

Record Enrolment on NHS ‘Soups and Shakes’ Programme After Study Shows One-Third Remission

Midlife Heart Damage Marker Tied to Higher Dementia Risk, 25-Year Study Finds

IIT Bombay Team Identifies Blood Metabolite Signals That May Flag Diabetic Kidney Disease Early

AI App Matches Human-Led Diabetes Prevention in Phase 3 Trial

PAMI Activates October Celiac Bonus, Updates Free Drug List, Keeps Eyeglasses and Flu Shots Free

Global Study Finds Nearly Half of People With Diabetes Are Undiagnosed

UK Launches Smartphone HbA1c Test for Type 2 Diabetes as NHS Pilot Begins

NICE Backs Six Digital Cardiac Rehab Tools for NHS Trial Use

Danish Cohort Study Finds No Health Risks from Aluminum Adjuvants in Childhood Vaccines

MHRA Recalls Four Batches of Flutiform Inhalers Over Dosage Labelling Error

GLP-1 Agonists Cut Dementia and Mortality Risk Versus Metformin in Type 2 Diabetes

France to Let All Doctors Prescribe Wegovy and Mounjaro Starting June 23

Bariatric Surgery Surpasses GLP-1 Drugs in Real-World Weight Loss

Italy Rolls Out Weekly Insulin Therapy Despite Regional Disparities

Global Experts Call to Double MASH Diagnoses After New Liver Disease Drug Approved